Design of human immunodeficiency virus-1 neutralizing peptides targeting CD4-binding site: An integrative computational biologics approach
Peptide therapeutics have recently gained momentum in antiviral therapy due to their increased potency and cost-effectiveness. Interaction of the HIV-1 envelope gp120 with the host CD4 receptor is a critical step for viral entry, and therefore the CD4-binding site (CD4bs) of gp120 is a potential hot...
Main Authors: | Sandhya Vivekanandan, Umashankar Vetrivel, Luke Elizabeth Hanna |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.1036874/full |
Similar Items
-
Enhancing Human Immunodeficiency Virus-specific CD8+ T cell Responses with Heteroclitic Peptides
by: Adeolu eAdegoke, et al.
Published: (2015-07-01) -
Development of peptide inhibitors of HIV transmission
by: Siyu Shi, et al.
Published: (2016-12-01) -
The W100 pocket on HIV-1 gp120 penetrated by b12 is not a target for other CD4bs monoclonal antibodies
by: Dueñas-Decamp Maria J, et al.
Published: (2012-01-01) -
Can Broadly Neutralizing HIV-1 Antibodies Help Achieve an ART-Free Remission?
by: Denise C. Hsu, et al.
Published: (2021-07-01) -
MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
by: Grupping Katrijn, et al.
Published: (2012-05-01)